New PBM contracting entities, often categorized as group purchasing organizations, add another obstacle to industry transparency
AMI’s Specialty Pharmacy Database continually monitors and tracks all limited and exclusive pharmacy distribution agreements
Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies
VHA Will Provide Coverage for Leqembi to Qualified Veterans with Early Alzheimer’s Disease, while the CMS continues to restrict its use
Walmart, Biologics and Avita Care Solutions Headline Recent Specialty Pharmacy Activities to consolidate and strengthen and expand their pharmacy reach and drug contracts
Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc
Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) Joins the SmithRx Pharmacy Network
Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs